|
For the reason most of
the conducted post marketing
surveillance trials are lacking
the means of mirroring the real
world of the studied drugs with
respect to safety and efficacy
after marketing and
dissemination to the general
population and that is due to
the inclusion of a limited
number of patients while having
a short periods of time studies,
In addition to the inadequate
representation of the patient
populations and the direct
comparison with drugs in the
same therapeutic class used for
the same indication; TPMC
e-clinical trials project idea
was born aiming to accomplish
the following objectives:
-
Insure the real representation
of a large scale population-wide
level of patients through an
extremely secured, controlled
and well organized high-end
methodologies of studying and
collecting data on efficacy,
safety and ADR reporting on a
wide range of - individually
studied - pharmaceutical drugs
throughout continued – long
period – of multiple phases of
this project life cycle.
-
Minimize the limitations in of
the clinical trials’ spontaneous
ADR reporting systems by
insuring an adequate reporting,
completion of the collected
data, multiple cross checks
between reported data and those
in patient files to ensure a
quality reported data.
-
Further understanding of safety
and efficacy aspects of a wide
range of individually studied
pharmaceutical drugs over a long
period of multiple phases
studies.
-
Prospective monitoring of new
health events in patients taking
selected prescription
medications.
-
Examining certain studies'
outcomes such as compliance,
costs, and productivity.
-
Helping the market analysis of
related medical studied
segments, product targeting, and
market strategy adjustment.
-
Implementing new strategies in
having more chances of
scientific based relations and
recognition in related studied
markets, as well as improving
doctors’ confidence in TPMC
drugs.
|
